PDS Biotechnology Corporation
PDSB
$1.26
$0.021.61%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -26.29% | -8.29% | -4.77% | 2.20% | -23.38% |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 34.89% | -8.00% | -10.94% | -26.05% | -6.23% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | -23.71% | -8.28% | -5.03% | 1.05% | -22.78% |
|
|||||
Total Current Assets | -23.71% | -8.28% | -5.03% | 1.05% | -22.78% |
Net Property, Plant & Equipment | -9.19% | -8.61% | -17.06% | -32.55% | -36.49% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | -23.63% | -8.28% | -5.11% | 0.81% | -22.88% |
|
|||||
Total Accounts Payable | -75.87% | -75.76% | -26.33% | 189.60% | 472.69% |
Total Accrued Expenses | 17.18% | 20.01% | -42.33% | -7.76% | -70.83% |
Short-term Debt | 200.00% | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 9.50% | 9.54% | -48.32% | -71.32% | -80.63% |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | 25.36% | 100.36% | 98.31% | 264.78% | 38.78% |
|
|||||
Total Current Liabilities | 25.36% | 100.36% | 98.31% | 264.78% | 38.78% |
Long-Term Debt | -52.81% | -48.61% | -40.61% | -28.05% | -15.27% |
Short-term Debt | 200.00% | -- | -- | -- | -- |
Capital Leases | -49.67% | -43.45% | -38.55% | -34.54% | -25.00% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | -20.76% | -6.89% | -5.53% | 15.98% | 0.77% |
|
|||||
Common Stock & APIC | 17.87% | 24.08% | 25.23% | 26.31% | 17.22% |
Retained Earnings | -26.03% | -30.36% | -33.14% | -39.46% | -42.28% |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | -27.27% | -10.14% | -4.70% | -9.33% | -40.61% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -27.27% | -10.14% | -4.70% | -9.33% | -40.61% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -27.27% | -10.14% | -4.70% | -9.33% | -40.61% |
|